Insulin is a key hormone regulating glucose homeostasis, intimately associated with glycaemia and is exposed to glycation by glucose, reducing sugars and other highly reactive carbonyls, particularly in diabetes. Glycation of insulin has been reported to differentially affect protein structure, stability and aggregation depending on the glycating agent and experimental conditions. Under reducing conditions glycation produces higher insulin oligomerization and, therefore, accelerates amyloid formation whereas, in non-reducing conditions, glycation inhibits amyloid formation. To better detail the effect of glycation on insulin malfunction and toxicity, we investigated the effect of another glycating agent, the D-ribose. Recently, ribosylation has attracted more attention due to its role in protein glycation and its subsequent effects such as protein aggregation, oxidative stress and cell death. Moreover, abnormally high concentration of D-ribose has been recently found in the urine of type II diabetics. Our results show that, using ribose, as glycating agent, the insulin conformation is preserved and does not evolve in amyloid aggregates because of the block of the α-helix to β-sheet transition, which initiates the aggregation process, maintaining the protein in a soluble monomeric state. At the same time, ribose-glycated insulin strongly affects the cell viability, starting a death pathway consisting in the activation of caspases 9 and 3/7, intracellular ROS production and activation of the transcription factor NF-kB

D-ribose-glycation of insulin prevents amyloid aggregation and produces cytotoxic adducts.

Borriello M;
2015-01-01

Abstract

Insulin is a key hormone regulating glucose homeostasis, intimately associated with glycaemia and is exposed to glycation by glucose, reducing sugars and other highly reactive carbonyls, particularly in diabetes. Glycation of insulin has been reported to differentially affect protein structure, stability and aggregation depending on the glycating agent and experimental conditions. Under reducing conditions glycation produces higher insulin oligomerization and, therefore, accelerates amyloid formation whereas, in non-reducing conditions, glycation inhibits amyloid formation. To better detail the effect of glycation on insulin malfunction and toxicity, we investigated the effect of another glycating agent, the D-ribose. Recently, ribosylation has attracted more attention due to its role in protein glycation and its subsequent effects such as protein aggregation, oxidative stress and cell death. Moreover, abnormally high concentration of D-ribose has been recently found in the urine of type II diabetics. Our results show that, using ribose, as glycating agent, the insulin conformation is preserved and does not evolve in amyloid aggregates because of the block of the α-helix to β-sheet transition, which initiates the aggregation process, maintaining the protein in a soluble monomeric state. At the same time, ribose-glycated insulin strongly affects the cell viability, starting a death pathway consisting in the activation of caspases 9 and 3/7, intracellular ROS production and activation of the transcription factor NF-kB
2015
Amyloid aggregation
Insulin glycation
Apoptosys
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12607/84478
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
social impact